Skip to main content
Watch Insiders
PTGXHealthcare

Protagonist Therapeutics Inc (PTGX) Insider Trading

In the last 90 days, 2 Protagonist Therapeutics Inc (PTGX) insiders reported no open-market purchases and 3 sales totaling $41,443,659. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Sep 30, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Sep 30, 2026Asif AliChief Financial OfficerSale58,629$141.78$8,312,296
Sep 10, 2026Dinesh V Ph D PatelPresident and CEOSale125,000$145.92$18,240,563
Aug 11, 2026Dinesh V Ph D PatelPresident and CEOSale100,000$148.91$14,890,800
Jun 23, 2026William D. WaddillCorporate insiderSale9,000$117.94$1,061,460
Jun 10, 2026William D. WaddillCorporate insiderSale9,000$107.68$969,120
May 29, 2026William D. WaddillCorporate insiderSale9,000$99.64$896,760
May 12, 2026Dinesh V Ph D PatelPresident and CEOSale75,000$100.12$7,509,000
May 8, 2026Bryan GiraudoCorporate insiderSale59,130$100.10$5,918,878
Apr 20, 2026Asif AliChief Financial OfficerSale1,750$105.47$184,573

Common questions

PTGX insider trading FAQ

Are PTGX insiders buying or selling?
Over the last 90 days, PTGX insiders were net sellers, reporting $0.00 of open-market purchases and $41,443,659 of sales.
When was the last PTGX insider purchase?
No open-market insider purchase of Protagonist Therapeutics Inc stock was reported in the last 90 days.
Where does PTGX insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Protagonist Therapeutics Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.